MEDLEYTSE:4480 -0.85%71 EBITDA Margin % is 32.63% as of Dec. 2025, which is 140% above its 10-year median of 13.62. GuruFocus rates TSE:4480 with a GF Score™ of 71/100 and a GF Value™ of 円6,724.37 (Significantly Undervalued). The stock has 4 warning signs investors should review. Among 668 Healthcare Providers & Services companies, MEDLEY ranks better than 58.68% on this metric.
EBITDA Margin % is calculated as EBITDA divided by its Revenue. MEDLEY's EBITDA for the
three
months ended in Dec. 2025 was 円3,018 Mil. MEDLEY's Revenue for the
three
months ended in Dec. 2025 was 円9,250 Mil. Therefore, MEDLEY's EBITDA margin for the quarter that ended in Dec. 2025 was 32.63%.
MEDLEY (TSE:4480) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
MEDLEY EBITDA Margin % Related Terms
MEDLEY EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for MEDLEY's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSE:4480 vs VEEV, BTSG, TEM: EBITDA Margin % Comparison
For the Health Information Services subindustry, MEDLEY's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
MEDLEY EBITDA Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, MEDLEY's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where MEDLEY's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MEDLEY (TSE:4480) has a EBITDA Margin % of 32.63% as of Dec. 2025. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on MEDLEY and its competitors. This is 140% above median its historical median of 13.62. According to the industry distribution chart, MEDLEY ranks #276 out of 668 companies in the Healthcare Providers & Services industry, placing it in the top 41.3%.
Is MEDLEY's EBITDA Margin % too high?
MEDLEY's current EBITDA Margin % of 32.63% is 140% above median its 10-year median of 13.62. The Healthcare Providers & Services industry median EBITDA Margin % is 10.21. MEDLEY's value of 32.63% is 219.6% above this industry median. Based on the distribution chart, MEDLEY ranks #276 out of 668 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, MEDLEY has a GF Score™ of 71/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does MEDLEY's EBITDA Margin % compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, MEDLEY ranks #276 out of 668 companies for EBITDA Margin %. This puts MEDLEY in the upper half of its industry. The industry median EBITDA Margin % is 10.21. MEDLEY's value of 32.63% is 219.6% above this benchmark. While the company's 10-year median is 13.62 vs. the industry median of 10.21, MEDLEY has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Healthcare Providers & Services company?
The median EBITDA Margin % among Healthcare Providers & Services companies is 10.21, based on 668 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. MEDLEY's current EBITDA Margin % of 32.63% is 219.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on MEDLEY and its competitors. For the Healthcare Providers & Services industry, the median EBITDA Margin % is 10.21 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. MEDLEY's current EBITDA Margin % is 32.63%, which is 140% above median its own 10-year median of 13.62. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MEDLEY stock overvalued right now?
Based on GuruFocus' analysis, MEDLEY (TSE:4480) is currently considered Significantly Undervalued. The stock's GF Value™ is 円6,724.37, compared to a current price of 円1,980.00 — trading 70.6% below its estimated fair value. The current EBITDA Margin % is 32.63%, which is 140% above median its 10-year median of 13.62 and 219.6% above the Healthcare Providers & Services industry median of 10.21. MEDLEY's overall GF Score™ is 71/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For MEDLEY (TSE:4480), the current EBITDA Margin % is 32.63% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is MEDLEY (TSE:4480) Overvalued in 2026?
Based on GuruFocus' analysis, MEDLEY stock appears to be undervalued.
The current stock price of 円1,980.00 is trading 70.6% below its estimated GF Value™ of 円6,724.37.
GuruFocus considers MEDLEY to be Significantly Undervalued.
Key valuation signals for TSE:4480:
EBITDA Margin %: 32.63% (140% above median its 10-year median of 13.62)
GF Value™: 円6,724.37 vs. price of 円1,980.00 (70.6% below fair value)
Industry Position: 219.6% above the Healthcare Providers & Services median (#276 of 668)
No single metric tells the full story. See the TSE:4480 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
MEDLEY Inc is engaged in providing medical information service for patients, and nursing care, a nursing care information service for citizens resolving issues in the field of medical healthcare. It provides its services through two platforms, Recruitment Platform Business which provides human resource recruitment systems in the medical and healthcare field and related businesses; and Medical Platform Business that is a telemedicine system for both patients and medical institutions.
71GF Score
Get the complete analysis for TSE:4480
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:4480 has been successfully added to your 
